October 2009: Special Products licenses epilepsy treatment to Phebra
October 2009: Cumberland Pharmaceuticals licenses Caldolor for ANZ
October 2009: Strategic partnership with Conventia Medical
October 2009: Haemorol™ (oily phenol injection) granted marketing approval
September 2009: Paraldehyde Injection has been granted marketing approval
August 2009: Tobra-day TM PBS Listing
August 2009: Marketing Approval - Glaumox TM
May 2009: New after hours emergency contact procedure for Phebra
May 2009: Phebra launches new website and online ordering system
Feb 2009: Phebra announces direct supply arrangements to Western Australia
Jan 2009: Marketing Approval for Brevibloc ® (esmolol) Injection
Nov 2007: PharmaLab changes name to Phebra